Population: Healthy infants aged 9 months – 2 years.

Intervention: Co-administration of MR/MMR and YF vaccines at the same vaccination visit.

Comparison(s): Administration of MR/MMR or YF vaccine individually, or sequentially with a period ≥28 days in-between individual vaccinations.

Outcome: Seroconversion and magnitude of antibody response (titers/antibody concentrations) following vaccination with YF and measles, mumps, rubella vaccines.

  • Evidence to recommendation table
  • Rubella